Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.36 |
| ▸ | CDK9 | P50750 | 2/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.34 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | PTK2 | Q05397 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3375825 | 0.84 | TSHR (0.50) | NPY5RTSHRCCNT1CDK9EGFR | |
| SCHEMBL10018351 | 0.80 | NPY5R (0.32) | NPY5RCCNT1CDK9EGFRHDAC1 | |
| SCHEMBL13444573 | 0.80 | NPY5R (0.32) | NPY5RCCNT1CDK9EGFRHDAC1 | |
| SCHEMBL13520156 | 0.80 | NPY5R (0.32) | NPY5RCCNT1CDK9EGFRHDAC1 | |
| SCHEMBL283016 | 0.79 | EGFR (0.47) | NPY5RTSHRCCNT1CDK9EGFR | |
| SCHEMBL16062693 | 0.78 | POLB (0.46) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL2493713 | 0.78 | TSHR (0.44) | NPY5RTSHRCCNT1CDK9EGFR | |
| SCHEMBL10866160 | 0.77 | NQO1 (0.52) | NPY5RTSHRCCNT1CDK9KDM4E | |
| SCHEMBL914644 | 0.77 | EGFR (0.46) | NPY5RTSHRCCNT1CDK9EGFR | |
| SCHEMBL23822678 | 0.77 | TSHR (0.43) | NPY5RTSHRCCNT1CDK9EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8203139-B2 | Organic thin film transistor and organic thin film light-emitting transistor using an organic semiconductor layer having an aromatic hydrocarbon group or an aromatic heterocyclic group in the center thereof | IDEMITSU KOSAN CO., LTD (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20110031487-A1 | COMPOUND FOR ORGANIC THIN-FILM TRANSISTOR AND ORGANIC THIN-FILM TRANSISTOR USING THE COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20100051919-A1 | ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM LIGHT-EMITTING TRANSISTOR | IDEMITSU KOSAN CO., LTD. (JP) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110031487-A1 | COMPOUND FOR ORGANIC THIN-FILM TRANSISTOR AND ORGANIC THIN-FILM TRANSISTOR USING THE COMPOUND | MLX, YBX1, HAX1 | NPY5R 1776/4885TSHR 1415/4885CCNT1 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.